CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-05-07 | TANG KEVIN C Director | Option exercise · Senior Secured Convertible Notes due 2021 | +0 | $2,400,000.00 | $0 | |
| 2012-05-07 | TANG KEVIN C Director | Option exercise · Rights to Purchase Senior Secured Convertible Notes due 2021 | −0 | |||
| 2011-07-08 | TANG KEVIN C Director | Grant or award · Non-Qualified Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2011-07-08 | ADAM MICHAEL A COO | Grant or award · Incentive Stock Option (right to buy) | +1,851,850 | 1,851,850 | ||
| 2011-07-08 | ADAM MICHAEL A COO | Grant or award · Non-Qualified Stock Option (right to buy) | +9,798,150 | 9,798,150 | ||
| 2011-07-08 | Whelan John President, CEO & CFO | Grant or award · Incentive Stock Option (right to buy) | +647,454 | 647,454 | ||
| 2011-07-08 | Whelan John President, CEO & CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +24,902,546 | 24,902,546 | ||
| 2011-07-08 | BARR JOHN Vice President of R&D | Grant or award · Incentive Stock Option (right to buy) | +677,697 | 677,697 | ||
| 2011-07-08 | BARR JOHN Vice President of R&D | Grant or award · Non-Qualified Stock Option (right to buy) | +6,322,303 | 6,322,303 | ||
| 2011-07-08 | TURNBULL GREG Director | Grant or award · Non-Qualified Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2011-07-08 | GODDARD PAUL Director | Grant or award · Non-Qualified Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2011-06-30 | Baker Brothers Life Sciences Capital (GP), LLC 10% owner | Other acquisition | +1,786 | 5,266,568 | ||
| 2011-06-30 | Baker Brothers Life Sciences Capital (GP), LLC 10% owner | Other acquisition · Senior Secured Convertible Notes due 2021 | +300 | 294,600 | ||
| 2011-06-30 | Baker Brothers Life Sciences Capital (GP), LLC 10% owner | Other acquisition · Rights to Purchase Senior Secured Convertible Notes due 2021 | +600 | 589,200 | ||
| 2011-06-30 | Baker Bros. Capital (GP), LLC 10% owner | Other disposition | −1,786 | 0 | ||
| 2011-06-30 | Baker Bros. Capital (GP), LLC 10% owner | Other disposition · Senior Secured Convertible Notes due 2021 | −300 | 0 | ||
| 2011-06-30 | Baker Bros. Capital (GP), LLC 10% owner | Other disposition · Rights to Purchase Senior Secured Convertible Notes due 2021 | −600 | 0 | ||
| 2011-06-29 | TANG KEVIN C Director | Grant or award | +50,000,000 | $0.15 | $7.5M | 60,436,506 |
| 2011-06-29 | TANG KEVIN C Director | Grant or award · Warrants (right to buy) | +25,000,000 | 25,000,000 | ||
| 2011-04-24 | TANG KEVIN C Director | Grant or award · Senior Secured Convertible Notes due 2021 | +0 | $1,200,000.00 | $0 |
Page 41 of 45 · 881 trades